MANAGING ANTERIOR SEGMENT INFECTIONS IN CHILDREN
|
|
- Felicity Lester
- 5 years ago
- Views:
Transcription
1 MANAGING ANTERIOR SEGMENT INFECTIONS IN CHILDREN Rachel A. Stacey Coulter, OD, MSEd, FAAO, Diplomate BVPPO Julie A. Tyler, OD, FAAO Nova Southeastern University College of Optometry, Fort Lauderdale, FL Please silence all mobile devices and remove items from chairs so others can sit. Unauthorized recording of this session is prohibited.
2 Disclosure Statement: Rachel'A.' 'Stacey 'Coulter,'OD,' MSEd,'FAAO,'Diplomate'BVPPO None Julie'A.'Tyler,'OD,'FAAO Virtual'advisory'board' optometric'educators,'shire
3 Considerations+in+managing+children+as+patients The$ever'changing$pediatric$patient Developmental$differences$among$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$ pediatric$age$groups Infants$ birth$to$one$year Toddlers$ one$to$three$years Preschool$ three$to$five$years School$age$ five$to$twelve$years Adolescents$ thirteen$to$eighteen$years
4 Differences)in)pharmacokinetic)responses)to) medications) Differences greatest in infants Differences in. Drug absorption Distribution Metabolism and excretion
5 Prescribing*challenges* Pediatric)Use)section Manufacturer s)drug)insert Age)for)which)the)drug)is)approved,)any) associated)side)effects)and)outcomes Off<label)prescribing) Pediatric)Use)section)states, Safety)and)effectiveness)in)children) have)not)been)established HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use AUGMENTIN safely and effectively. See full prescribing information for AUGMENTIN. AUGMENTIN (amoxicillin/clavulanate potassium) Tablets, Powder for Oral Suspension, and Chewable Tablets Initial U.S. Approval: 1984 To reduce the development of drug-resistant bacteria and maintain the effectiveness of AUGMENTIN and other antibacterial drugs, AUGMENTIN should be used only to treat infections that are proven or strongly suspected to be caused by bacteria INDICATIONS AND USAGE AUGMENTIN is a combination penicillin-class antibacterial and beta-lactamase inhibitor indicated for treatment of the following: Lower respiratory tract infections (1.1) Acute bacterial otitis media (1.2) Sinusitis (1.3) Skin and skin structure infections (1.4) Urinary tract infections (1.5) DOSAGE AND ADMINISTRATION Adults and Pediatric Patients > 40 kg: 500 or 875 mg every 12 hours or 250 or 500 mg every 8 hours. (2.1, 2.2) Pediatric patients aged 12 weeks (3 months) and older: 25 to 45 mg/kg/day every 12 hours or 20 to 40 mg/kg/day every 8 hours, up to the adult dose. (2.2) Neonates and infants < 12 weeks of age: 30 mg/kg/day divided every 12 hours, based on the amoxicillin component. Use of the 125 mg/5 ml oral suspension is recommended. (2.2) DOSAGE FORMS AND STRENGTHS Formulations and amoxicillin/clavulanate content are: Tablets: 250 mg/125 mg, 500 mg/125 mg, 875 mg/125 mg; 875 mg/125 mg tablets are scored. (3) Powder for Oral Suspension: 125 mg/31.25 mg per 5 ml, 200 mg/28.5 mg per 5 ml, 250 mg/62.5 mg per 5 ml, 400 mg/57 mg per 5 ml (3) Chewable Tablets: 125 mg/31.25 mg, 200 mg/28.5 mg, 250 mg/62.5 mg, 400 mg/57 mg (3) FULL PRESCRIBING INFORMATION: CONTENTS* 1 INDICATIONS AND USAGE 1.1 Lower Respiratory Tract Infections 1.2 Acute Bacterial Otitis Media 1.3 Sinusitis 1.4 Skin and Skin Structure Infections 1.5 Urinary Tract Infections 1.6 Limitations of Use 2 DOSAGE AND ADMINISTRATION 2.1 Adults 2.2 Pediatric Patients 2.3 Patients with Renal Impairment 2.4 Directions for Mixing Oral Suspension 3 DOSAGE FORMS AND STRENGTHS 4 CONTRAINDICATIONS 4.1 Serious Hypersensitivity Reactions 4.2 Cholestatic Jaundice/Hepatic Dysfunction 5 WARNINGS AND PRECAUTIONS 5.1 Hypersensitivity Reactions 5.2 Hepatic Dysfunction 5.3 Clostridium difficile-associated Diarrhea 5.4 Skin Rash in Patients with Mononucleosis 5.5 Potential for Microbial Overgrowth 5.6 Phenylketonurics 5.7 Development of Drug-Resistant Bacteria Reference ID: CONTRAINDICATIONS History of a serious hypersensitivity reaction (e.g., anaphylaxis or Stevens-Johnson syndrome) to AUGMENTIN or to other beta-lactams (e.g., penicillins or cephalosporins) (4) History of cholestatic jaundice/hepatic dysfunction associated with AUGMENTIN. (4) WARNINGS AND PRECAUTIONS Serious (including fatal) hypersensitivity reactions: Discontinue AUGMENTIN if a reaction occurs. (5.1) Hepatic dysfunction and cholestatic jaundice: Discontinue if signs/symptoms of hepatitis occur. Monitor liver function tests in patients with hepatic impairment. (5.2) Clostridium difficile-associated diarrhea (CDAD): Evaluate patients if diarrhea occurs. (5.3) Patients with mononucleosis who receive AUGMENTIN develop skin rash. Avoid AUGMENTIN use in these patients. (5.4) Overgrowth: The possibility of superinfections with fungal or bacterial pathogens should be considered during therapy. (5.5) ADVERSE REACTIONS The most frequently reported adverse effects were diarrhea/loose stools (9%), nausea (3%), skin rashes and urticaria (3%), vomiting (1%) and vaginitis (1%) (6.1) To report SUSPECTED ADVERSE REACTIONS, contact GlaxoSmithKline at or FDA at FDA-1088 or DRUG INTERACTIONS Co-administration with probenecid is not recommended. (7.1) Concomitant use of AUGMENTIN and oral anticoagulants may increase the prolongation of prothrombin time. (7.2) Coadministration with allopurinol increases the risk of rash. (7.3) AUGMENTIN may reduce efficacy of oral contraceptives. (7.4) USE IN SPECIFIC POPULATIONS Pediatric Use: Modify dose in patients 12 weeks or younger. (8.4) Renal impairment; Dosage adjustment is recommended for severe renal impairment (GFR< 30mL/min). (2.3, 8.6) See 17 for PATIENT COUNSELING INFORMATION and FDAapproved patient labeling. Revised: 01/2013 XXXXXXXXX 6 ADVERSE REACTIONS 6.1 Clinical Trials Experience 6.2 Postmarketing Experience 7 DRUG INTERACTIONS 7.1 Probenecid 7.2 Oral Anticoagulants 7.3 Allopurinol 7.4 Oral Contraceptives 7.5 Effects on Laboratory Tests 8 USE IN SPECIFIC POPULATIONS 8.1 Pregnancy 8.2 Labor and Delivery 8.3 Nursing Mothers 8.4 Pediatric Use 8.5 Geriatric Use 8.6 Dosing in Renal Impairment 10 OVERDOSAGE 11 DESCRIPTION 12 CLINICAL PHARMACOLOGY 12.1 Mechanism of Action 12.3 Pharmacokinetics 12.4 Microbiology 13 NONCLINICAL TOXICOLOGY 13.1 Carcinogenesis, Mutagenesis, Impairment of Fertility
6 Prescribing*challenges:*Off1label* considerations Eye$drops$and$dermatologic$preparations$are$the$most$likely$ prescribed$off6label$medications Off6label$education$and$prescribing$considerations Check$package$insert$and$FDA$website$for$warnings$or$contraindications!Example:$$Doxycycline$and$other$tetracycline$analogues$cause$ abnormalities$in$children$younger$than$eight Discuss$whether$or$not$the$drug$has$been$approved$for$pediatric$use Document$the$decision6making$process$and$the$parent s/guardian s$consent$ in$the$medical$record.
7 Prescribing*challenges:*Off1label*considerations Best*source*! Dosage(and(Administration(section(of(package(insert If(not(available( other(common(adaptations(for(topical( pharmaceuticals Cut(Dose 1/2(adult(dose(for(children(<(2(yrs 2/3(adult(dose(for(children(ages(2( 3(yrs Decrease(frequency(of(dosing( When(available,(use(lower(percentage(of(mediation((eg,(olapatadine)
8 Determining&dosage ORAL%medications%adjusted%according%to%body%weight%(mg/kg/day)%and%many% medications%for%children%are prescribed)as)mg/kg,)mcg/kg)or)units/kg Weigh&patient&in&office;&don t&rely&on&reported&weight Four%Step%Approach: (1)%convert%pounds%to%kg%(1kg%=%2.2lb) (2)%calculate%the%dose%in%mg (3)%divide%dose%by%frequency%needed%for%oral%solutions/suspensions (4)%convert%mg/dose%to%mL Image:% GCh1blQPDEAQYAyABEgK9MfD_BwE&sku=477&utm_campaign=google_shopping&utm_medium=shopping&utm_source=google
9 Differences)in)diagnosis:))History Pediatric)patients)may)be)unable)or)unlikely)to)report)their)symptoms Diagnosis)often)made)by: Findings) History)reported)by)parent)or)caregiver)including: Duration Laterality Discharge Presence)of)pain)and)photophobia History)of)trauma)or)exposure)to)someone)else)with)red)eye
10 Common%Anterior%Segment%Infections%
11 Pediatric)Red)Eyes 1"%"primary"care"office"visits"="conjunctivitis Causes"of" red"eyes " infection,"allergy,"trauma,"dryness,"systemic" inflammation History Duration"symptoms Pain"present Photophobia Hx of"traumac high"or"low"velocity Prior"red"eyes/Previous"treatment
12 Blepharitis Pediatric)presentation Most)commonly)presents)in)children)age)6)5 10)yrs Symptoms)and)signs Injection)and/or)vessel)telangiectasia)along)lid) margin Hard,)fibrinous)crusts)and)scales) Occasional)misdirected)or)missing)lashes Staphylococcus overgrowth)5major)causative) factor)
13 Blepharitis Treatment(agents Lid(hygiene( Lid(scrubs( diluted(baby(shampoo(applied(to(lid(margins Commercial(wipes Systane lid(wipes((alcon)( Ocusoft lid(scrubs(available(in(a( baby (formulations Dandruff(ShampoosCseborrheic(blepharitis
14 Topical(agents Topical(antibiotic(options(when(indicated Erythromycin+ointment+ 1/2x+daily+x+2+weeks When+using+ointments,+apply+close+to+bedtime+to+decrease+ blur+ Azasite Conjunctivitis+dosing:+2x+daily+x+2+days,+then+1x+for+5+days Targets+Staphylococcus,AND+MGD+via+immunomodulatory+response Approved+>12+mos Expensive Fluoroquinolones Besivance (besifloxacin)+0.6%+ophthalmic+suspension Ciloxan (ciprofloxacin)+0.3%+solution Others/ ofloxacin,+moxifloxacin+and+gatifloxacin
15 Topical(Agents Topical(antibiotic/steroid(combinations Warranted(in(severe(cases,(to(eliminate(inflammation/(complications(of( bacteria((eg,(exotoxins)(with(concurrent(bacterial(overgrowth Ointments(may(be(easier(to(administer Options(include( Tobradex (tobramycin+and+dexamethasone+ophthalmic+suspension,+ Alcon)( Neomycin/polymyxin B/dexamethasone Considerations(in(Steroid(Use Side(effects( elevated(iop(and(cataract(formation If(HSV(is(culprit,(cornea(at(increased(risk(of(complications Clinicians(should(weigh(dosing(frequency(and(risks/benefits(
16 Blepharitis&? Oral Prescribing*oral*medications Azithromycin*(macrolide6type*antibiotic) Both*anti6inflammatory*and*antibacterial*properties Studies*in*adults*=*1*gram*for*3*weeks Approved*for*children*> age*six*months Example:*Treatment*options:* SINUSITIS&Dosing:&Child&dosage&(ages&6&months&to&17&years) Typical*dosage*is*10*mg/kg*of*body*weight*once*per*day*for*three*days.
17 Blepharitis+ Additional+considerations Additional)considerations:)Hypochlorous acid)treatments) (eg,%rx:%avenova [30%day%shelf%life%open],%Non;Rx:%HypoChlor Gel%0.02%%and%OcuSoft HypoChlor Spray%.02%[18month%shelf%life%open%or%closed) Manages)bacterial)overpopulation,)penetrates)biofilm,)inactivates) lipase)! Approved)for)blepharitis Spray)application!) Tea)tree)oil)treatments Nutrition
18 Hordeola Symptoms(and(signs Focal(infections(of(eyelid(glands Signs:( Localized(swelling,(pain(and(redness Pediatric(presentation Usually(caused(by(Staphylococcus,aureus
19 Hordeola Treatment)agents Warm)compress) apply)10>15)min Considerations: Topical)antibiotic)agents)> prevent) infection)spread)when) drainage/expression)is)significant,) especially)with)external)hordeolum Oral)antibiotics)may)be)needed)if) progresses)to)preseptal cellulitis Strategies)for)pediatric) compliance Freeze /music)game
20 Viral&conjunctivitis Symptoms(and(signs Usually(bilateral symptoms(starting(in(one(eye( and(progress(to(other(eye Red,(watery(eyes;(sometimes(small( (sub)conjunctival(hemorrhages Swollen(pre?auricular(nodes(in(children(with( developed(immune(systems Hx exposure(to(sick(people? Causes( usually(adenovirus,(although(hsv(&(varicella( zoster(possible
21 Viral&conjunctivitis Some&adenoviral&conjunctivitis&sub4types& (EKC)&! possible(delayed(corneal(response( with(sub3epithelial(infiltrates( (keratoconjunctivitis) Clinicians(should(emphasize(to(patient( and(parent(with(patient(education( regarding(expected(outcomes(and(the( importance(of(follow3up
22 Viral&conjunctivitis Pediatric)presentation Self1limiting)condition symptoms)usually)decrease)within)first)week Contagious)for)10121)days Palliative)measures)such)as)cool)compresses)and)artificial)tears)(PF) No)current)ophthalmic)agents)are)approved)for)adenoviral)infections
23 Prevent'spread'of'infection Educate(the(patient(and(caregiver(on(proper(hygiene(practices: Avoid(touching(the(eyes(or(eye(area. Use(disposable(tissues(and(wipes(instead(of(towels. Wash(hands(immediately(after(touching(the(eyes(or(eye(area. Don t(share(towels,(washcloths,(dishes,(cups(or(eating(utensils. Play(with(hard(surface(toys(that(can(be(thoroughly(cleaned. Discuss(the(need(to(keep(children(out(of(daycare(or(school( Complete(notes(or(documentation(required(for(absences(or(reentry
24 Microbial)conjunctivitis Presentation Generally,.sticky.mucopurulent.discharge. Eyelids. stick.together Bacterial.Causes: Staphylococcus,aureus,,Staphylococcus,epidermis,,Streptococcus, pneumoniae,,moraxella,catarrhalis,,pseudomonas,and,haemophilus
25 Bacterial)conjunctivitis Topical(antibiotics(- broad-spectrum(antibiotic(effective(against( Gram((+),(Gram((-) Erythromycin(0.5%( Antibiotic(combination(options: polymyxin B(sulfate(and(trimethoprim(sulfate(ophthalmic(solution polymyxin B/bacitracin(ophthalmic(ointment(and(erythromycin(0.5%( Aminoglycosides: Pro:((Often(inexpensive Con:(Less(desirable(due(to(corneal(epithelial(toxicity(reaction( Azithromycin,(AzaSite Multiple( pros(and(cons
26 Specific'notes'on'topical'azithromycin,-AzaSite Effectivity:''Beneficial'for'acute'bacterial'conjunctivitis Unique'dosing'regimen:' Dosed'one'drop'twice'daily,'eight'to'12'hours'apart'x'two'days;' then'once'daily'for'next'five'days Total'='9'drops Viscous'vehicle'enhances'contact'with'the'eye'and'enables'rubbing' excess 'drop'along'lid'margins'to'target'concurrent'eyelid'infection Cons:'Cost'and'availability Oral'antibiotics Bacterial-conjunctivitis
27 Viral&(HSV)&keratitis&with&a& primary&corneal&defect Symptoms(and(signs( conjunctival(injection,( follicles,(corneal(staining(with(rose(bengal or( discrete(punctuate(defects,(classic(dendrite Pediatric(presentation
28 Viral&keratitis&with&a&primary&corneal&defect Antivirals Trifluridine 1%1 Dosed1up1to1nine1times1per1day1 Disadvantage18 corneal1toxicity1over1time Zirgan (ganciclovir)1ophthalmic1gel10.15% Less1corneal1toxicity1than1trifluridine,1less1frequent1dosing,1 gel1formulation1that1may1be1preferable Approved1age1> 21years1 Oral1consideration Co8management
29 Fungal'keratitis History( Contact(lens(wearer?(Trauma? Thickened,(feathery,(poorly(defined(corneal(lesion Not(responsive(to(antibiotic Pediatric(presentation Most(common(risk(factor(=(trauma(with(plants( material Also(associated(with(trauma(from(metal,( pieces,(firecrackers,(pencils Treatment(antifungals Topical Systemic(
30 Preseptal cellulitis Symptoms(and(signs Lid(swelling(and(redness Fever Discharge R/O(!orbital(cellulitis( Proptosis,(decreased(ocular(motility,(severe(pain,(APD,(optic( nerve(head(edema,(decreased(va Pediatric(presentation Caused(by(BSinusitis,(hordolea,(dacryocystitis,(trauma(and(insect(bite
31 Preseptal cellulitis Treatment Oral%antibiotics Augmentin%(amoxicillin%+clauvanate) Monitor%for%progression
32 Preseptal cellulitis
33 Additional)management)considerations
34 Preventing)spread)of)infection Educate(the(patient(and(caregiver(on(proper(hygiene(practices: Avoid(touching(the(eyes(or(eye(area. Use(disposable(tissues(and(wipes(instead(of(towels. Wash(hands(immediately(after(touching(the(eyes(or(eye(area. Don t(share(towels,(washcloths,(dishes,(cups(or(eating(utensils. Play(with(hard(surface(toys(that(can(be(thoroughly(cleaned. Discuss(the(need(to(keep(children(out(of(daycare(or(school( Complete(notes(or(documentation(required(for(absences(or(reentry
35 Scheduling+treatment Set$family$up$for$success Consider$family$schedules$ Coordinate$with$regular$family$activities$to$improve$compliance Recommend$caregiver$administer$the$medication$at$regular$family$ activities$(breakfast,$after$school,$bedtime$may$improve$compliance)
36 Communication Touching)base)with)patient s)family)and)other)providers When)prescribing)an)oral)medication,)follow)up)with)a)phone)call)to)check)on) the)patient s)status)and)review)any)concerns. Document)these)phone)calls)in)the)patient s)record.) Call)or)write)to)the)child s)pediatrician)regarding)the)condition)and)any) prescribed)medication.) Be)sure)to)document)this)communication)in)the)medical)record.)
37 Case%Studies
38 5"year'old'female'presents'with'itchy'eyelids,'reddened'lid' margins;'no'discharge Other'findings7 inferior'corneal'staining History' third'episode'in'five'months Most'likely'diagnosis? Management'options?
39 12#year(old(male(who$has$Spina$Bifida$presents$with$swollen$lids,$ itchy$red$eyes $and$watery$discharge Other$symptoms$: pain$and$severe$foreign:body$sensation History: His$mother$noted$started$a$few$days$earlier,$when$he$felt$ itchiness$in$his$right$eye$that$appeared$inflamed Most(likely(diagnosis? Management(options?
40 7"year'old'female'presents'painful,'swollen'left'eyelid'x'two'days' Other'findings'6 low6grade'fever;'swollen'left'preauricular node VA'20/20'OD'and'OS' Most'likely'Diagnosis? Management'options?
41 4"year'old'male'presents'with'a'red'eye,'that'is'not'resolving History'4 Being'treated'with'Polytrim (dosed'appropriately)' Findings4 Appears'to'be'keratoconjunctivitis with'significant' corneal'staining'(pek),'papillae,'and'mucopurulent'discharge.' What'is'your'next'step?
42 13#year(old(male(complains*of*intense*itching*x*several*weeks Other*findings7 swollen*eyelids,*injection,*chemosis,*large* papillae,*mucus*strings*and*strands*ou; OD*cornea*has*2*x*3* mm*area*of*excavation,*3+*anterior*chamber*reaction* Most(likely(diagnosis?( Management(options?
43 Thank you for your interest and attention! Have questions? Please feel free to contact us Rachel'A.' 'Stacey 'Coulter,'OD,' MSEd,'FAAO,'Diplomate'BVPPO Julie A. Tyler, OD, FAAO
44 Please&remember&to&complete&your& session&evaluations&on&the&academy.18&meeting&app Tweet&about&this&session&using& the&official&meeting&hashtag& #Academy18+
Announcing an automatic patient savings program
Pharmacy E change Volume 17, Number 3 August 2016 Web Version New from Mylan Generic for Doryx (doxycycline hyclate delayed-release tablets) 1,2 Now Available from Mylan in 50 mg and 200 mg dosage strengths
More informationWARNING: TENDON EFFECTS and EXACERBATION OF MYASTHENIA GRAVIS
DECLESAU (dergrafloxacin) tablets, for oral use DECLESAU (dergrafloxacin) injection, solution for intravenous use WARNING: TENDON EFFECTS and EXACERBATION OF MYASTHENIA GRAVIS Fluoroquinolones, including
More informationAXITAB-CV TAB. COMPOSITION :
AXITAB-CV TAB. COMPOSITION : Each film coated tablet contains: Cefuroxime Axetil I.P. Eq. to Anhydrous 500mg. Potassium Clavulanate Diluted I.P. Eq. to Clavulanic Acid 125mg DESCRIPTION : Cefuroxime Axetil
More informationADVERSE REACTIONS The most common (>10%) adverse reactions are hypercalcemia, nausea, and diarrhea. (6.
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use PHOSLYRA safely and effectively. See full prescribing information for PHOSLYRA. PHOSLYRA (calcium
More informationAnnex I: Proposed Core Safety Profile (CSP) 4.3 Contraindications
Annex I: Proposed Core Safety Profile (CSP) 4.3 Contraindications Hypersensitivity to cefuroxime or to any of the excipients listed in section 6.1. Patients with known hypersensitivity to cephalosporin
More informationStaphylococcal enterocolitis: Adult Patients (18 years of age and older): 500 mg to 2 g orally in 3 or 4 divided doses for 7 to 10 days. (2.
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use FIRVANQ safely and effectively. See full prescribing information for FIRVANQ. FIRVANQ (vancomycin
More information3 DOSAGE FORMS AND STRENGTHS
PATADAY- olopatadine hydrochloride solution/ drops Alcon Laboratories, Inc. ---------- HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use PATADAY safely
More informationROSOBAC-1GM / ROSOBAC-FORT
ROSOBAC-1GM / ROSOBAC-FORT ROSOBAC - 1GM. COMPOSITION : Each vial contains Sterile Cefoperazone Sodium IP Eq. to Anhydrous Cefoperazone - Sterile Sulbactam Sodium USP Eq. to Anhydrous Sulbactam - ROSOBAC
More informationImmodium / loprarmide
Immodium / loprarmide IMODIUM (loperamide hydrochloride) is indicated for the control and symptomatic relief of acute nonspecific diarrhea and of chronic diarrhea associated with inflammatory bowel disease.
More informationFULL PRESCRIBING INFORMATION: CONTENTS*
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use OTIPRIO safely and effectively. See full prescribing information for OTIPRIO. OTIPRIO (ciprofloxacin
More informationPage 1 of 13. CEFIXIME for oral suspension, 100 mg/5 ml CEFIXIME for oral suspension, 200 mg/5 ml For oral administration
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use cefixime for oral suspension safely and effectively. See full prescribing information for cefixime
More informationReference ID:
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use LYSODREN safely and effectively. See full prescribing information for LYSODREN. LYSODREN (mitotane)
More informationVANLID Capsules (Vancomycin hydrochloride)
Published on: 22 Sep 2014 VANLID Capsules (Vancomycin hydrochloride) Composition VANLID Capsules Each capsule contains: Vancomycin Hydrochloride IP equivalent to Vancomycin.. 250 mg Approved colours used
More informationZINEX. Composition Each tablet contains Cefuroxime (as axetil) 250 or 500 mg
ZINEX Composition Each tablet contains Cefuroxime (as axetil) 250 or 500 mg Tablets Action Cefuroxime axetil owes its bactericidal activity to the parent compound cefuroxime. Cefuroxime is a well-characterized
More informationM0BCore Safety Profile
M0BCore Safety Profile Active substance: Aztreonam Pharmaceutical form(s)/strength: 500 mg, 1 g and 2 g powder for solution for injection and infusion NB! 75mg aztreonam for nebulisation to treat infections
More informationKEVEYIS (dichlorphenamide) tablets, for oral use Initial U.S. Approval: 1958
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use KEVEYIS safely and effectively. See full prescribing information for KEVEYIS. KEVEYIS (dichlorphenamide)
More informationHigh dose amoxicillin for sinusitis
High dose amoxicillin for sinusitis Amoxil ( amoxicillin ) is a commonly used penicillin antibiotic. It is produced in tablets (500 mg 875 mg), capsules, chewable tablets and oral suspensions. 6-3-2018
More informationNEOSPORIN Ophthalmic Solution Sterile (neomycin and polymyxin B sulfates and gramicidin ophthalmic solution, USP)
NEOSPORIN Ophthalmic Solution Sterile (neomycin and polymyxin B sulfates and gramicidin ophthalmic solution, USP) NEOSPORIN SOLUTION DESCRIPTION NEOSPORIN Ophthalmic Solution (neomycin and polymyxin B
More informationColistimethate FOR INJECTION, USP 10 DIGIT NDC STRENGTH SIZE WHOLESALE NUMBERS WEB LISTING. 150 mg*/vial 12
Colistimethate FOR INJECTION, USP 10 DIGIT NDC STRENGTH SIZE WHOLESALE NUMBERS WEB LISTING 39822-0617-1 150 mg*/vial 1 ABC 10167618 Cardinal 5276001 11 DIGIT NDC Colistin base activity vial McKesson 3574043
More informationXerava (eravacycline) NEW PRODUCT SLIDESHOW
Xerava (eravacycline) NEW PRODUCT SLIDESHOW Introduction Brand name: Xerava Generic name: Eravacycline Pharmacological class: Tetracycline antibiotic Strength and Formulation: 50mg; per vial; lyophilized
More informationM0BCore Safety Profile
M0BCore Safety Profile Active substance: Aciclovir Pharmaceutical form(s)/strength: Tablets 200, 400 or 800 mg Dispersible tablets 200, 400 or 800 mg Oral suspensions 200 mg or 400 mg per 5 ml. Freeze
More informationVI.2 Elements for a public summary. VI.2.1 Overview of disease epidemiology
VI.2 Elements for a public summary VI.2.1 Overview of disease epidemiology Sinus infection (Acute bacterial sinusitis) Sinus infection (upper respiratory infection) is short-lived infection of the sinuses,
More informationAMPICLOX TM Ampicillin-cloxacillin
AMPICLOX TM Ampicillin-cloxacillin QUALITATIVE AND QUANTITATIVE COMPOSITION AMPICLOX 500mg Capsules: Each capsule contains 250 mg ampicillin as Ampicillin Trihydrate and 250 mg cloxacillin as Cloxacillin
More informationPage 1 of 21. Adult Patients and Pediatric Patients Dosage Guidelines for Cefuroxime Axetil Tablets USP. Infection
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use Cefuroxime Axetil Tablets USP safely and effectively. See full prescribing information for Cefuroxime
More informationRevised: 10/2016 FULL PRESCRIBING INFORMATION: CONTENTS*
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use VERMOX CHEWABLE safely and effectively. See full prescribing information for VERMOX CHEWABLE. VERMOX
More informationReference ID: single. Uncomplicated gonorrhea
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use CEFTIN safely and effectively. See full prescribing information for CEFTIN. CEFTIN (cefuroxime axetil)
More informationDOSAGE FORMS AND STRENGTHS Cream: Each gram contains 10 mg of ozenoxacin (1%) (3).
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use XEPI TM safely and effectively. See full prescribing information for XEPI TM. XEPI TM (ozenoxacin)
More informationAEMCOLO (rifamycin) delayed-release tablets, for oral use. Initial U.S. Approval: 2018
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use AEMCOLO safely and effectively. See full prescribing information for AEMCOLO. AEMCOLO (rifamycin)
More informationPharmaceutical form(s)/strength: Capsules, 200mg, 400mg, Oral suspensions, 90mg/5ml, 180mg/5ml, 36 mg/ml SI/H/PSUR/0002/002 Date of FAR:
0BCore Safety Profile Active substance: Ceftibuten Pharmaceutical form(s)/strength: Capsules, 200mg, 400mg, Oral suspensions, 90mg/5ml, 180mg/5ml, 36 mg/ml P-RMS: SI/H/PSUR/0002/002 Date of FAR: 14.02.2013
More informationReference ID:
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use CEFAZOLIN injection safely and effectively. See full prescribing information for CEFAZOLIN injection.
More informationCONTRAINDICATIONS None (4)
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use Cystadane safely and effectively. See full prescribing information for Cystadane. Cystadane (betaine
More informationCONTRAINDICATIONS None.
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use PAZEO safely and effectively. See full prescribing information for PAZEO. PAZEO (olopatadine hydrochloride
More informationBeta-lactamase production should have no effect on Azithromycin activity.
AZIMEX Composition Azimex 250 Capsules Each capsule contains Azithromycin (as dihydrate) 250 mg Capsules Azimex 500 mg Capsules Each capsule contains Azithromycin (as dihydrate) 500 mg Action Azithromycin
More informationReference ID:
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use TRIFERIC safely and effectively. See full prescribing information for TRIFERIC. TRIFERIC (ferric
More informationAdults and Adolescents (13 years and older) Pharyngitis/tonsillitis (mild to moderate) 500 mg. every 12 hours. (mild to moderate) every 12 hours
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use CEFUROXIME AXETIL TABLETS safely and effectively. See full prescribing information for CEFUROXIME
More informationCEFADUR Tablet (Cefadroxil)
Published on: 23 Sep 2014 CEFADUR Tablet (Cefadroxil) Composition CEFADUR-500 Each Film-coated tablet contains Cefadroxil IP equivalent to Cefadroxil anhydrous...500 CEFADUR 125 DT Each dispersible uncoated
More information1 INDICATIONS AND USAGE. 1.1 Limitation of Use FULL PRESCRIBING INFORMATION
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use TRIFERIC safely and effectively. See full prescribing information for TRIFERIC. TRIFERIC (ferric
More informationThe score line is only to facilitate breaking for ease of swallowing and not to divide into equal doses.
1. NAME OF THE MEDICINAL PRODUCT Avopenin 800 mg film-coated tablets Avopenin 1 g film-coated tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Phenoxymethylpenicillin potassium 800 mg or 1 g For a full
More informationSummary of Product Characteristics
Summary of Product Characteristics 1 NAME OF THE MEDICINAL PRODUCT Keftid Capsules 250 mg 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Per Capsule Cefaclor Monohydrate Equivalent to Cefaclor 250.00mg For
More informationPRESCRIBING INFORMATION. Cloxacillin for Injection. Cloxacillin Powder for Solution (as cloxacillin sodium) 500mg powder/vial.
PRESCRIBING INFORMATION Pr Cloxacillin for Injection Cloxacillin Powder for Solution (as cloxacillin sodium) 500mg powder/vial 1g powder/vial 2g powder/vial 10g powder/vial STERILE Antibiotic SteriMax
More informationBeta-lactamase production should have no effect on Azithromycin activity.
AZIMEX Composition Azimex 250 Capsules Each capsule contains Azithromycin (as dihydrate) 250 mg Capsules & Powder Azimex 500 mg Capsules Each capsule contains Azithromycin (as dihydrate) 500 mg Azimex
More informationTreatment of mild-to-moderate PCP in adults and adolescents aged 13 years and older who cannot tolerate TMP-SMX. (1.2)
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use MEPRON oral suspension safely and effectively. See full prescribing information for MEPRON oral suspension.
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Clonamox 125mg/5ml and 250mg/5ml Powder for Oral Suspension 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Clonamox 125 mg/5 ml: Each 5ml
More informationPRESCRIBING INFORMATION. Cloxacillin Powder for Solution (as cloxacillin sodium) 500mg powder/vial. 1g powder/vial. 2g powder/vial.
PRESCRIBING INFORMATION Pr Cloxacillin for Injection Cloxacillin Powder for Solution (as cloxacillin sodium) 500mg powder/vial 1g powder/vial 2g powder/vial 10g powder/vial STERILE Antibiotic SteriMax
More informationUncomplicated skin and skin-structure 250 or 500 mg every hours Uncomplicated urinary tract infections 250 mg every 12 7 to 10
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use CEFTIN safely and effectively. See full prescribing information for CEFTIN. CEFTIN (cefuroxime axetil)
More informationAmoxitid 125 Suspension Each teaspoonful (5 ml) contains Amoxicillin (as trihydrate) 125 mg.
AMOXITID Composition Amoxitid 250 Capsules Each capsule contains Amoxicillin (as trihydrate) 250 mg. Capsules & Suspension Amoxitid 500 Capsules Each capsule contains Amoxicillin (as trihydrate) 500 mg.
More informationSUCRALFATE TABLETS, USP
1234567890 10 210002-01 SUCRALFATE TABLETS, USP DESCRIPTION Sucralfate is an -D-glucopyranoside, -D-fructofuranosyl-, octakis-(hydrogen sulfate), aluminum complex. It has the following structural formula:
More information1 followed by 5 mg/kg once daily. ZITHROMAX (azithromycin) 250 mg and 500 mg Tablets and Oral Suspension Initial U.S.
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ZITHROMAX safely and effectively. See full prescribing information for ZITHROMAX. Pharyngitis/tonsillitis
More informationFarmadol. Paracetamol 10 mg/ml INFUSION SOLUTION
Farmadol Paracetamol 10 mg/ml INFUSION SOLUTION Composition Each ml contains: Paracetamol 10 mg Pharmacology Pharmacodynamic properties The precise mechanism of the analgesic and antipyretic properties
More informationGlucaGen (glucagon [rdna origin] for injection) Initial U.S. Approval: 1998
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use GlucaGen safely and effectively. See full prescribing information for GlucaGen. GlucaGen (glucagon
More informationMetabolism Paracetamol is metabolised in the liver and excreted in the urine mainly as glucuronide and sulphate conjugates.
FEBRAMOL Composition Febramol 150 Suppositories Each suppository contains Paracetamol 150 mg. Suppositories, Tablets & Syrup Febramol 300 Suppositories Each suppository contains Paracetamol 300 mg. Each
More informationPACKAGE INSERT USP ANTIBIOTIC
Pr AMPICILLIN for Injection USP ANTIBIOTIC ACTIONS AND CLINICAL PHARMACOLOGY Ampicillin has a broad spectrum of bactericidal activity against many gram-positive and gramnegative aerobic and anaerobic bacteria.
More informationRECENT MAJOR CHANGES Warnings and Precautions, Hemophagocytic
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use LAMICTAL safely and effectively. See full prescribing information for LAMICTAL. LAMICTAL (lamotrigine)
More informationCefadroxil for Oral Suspension USP 250 mg/5 ml and 500 mg/5 ml
Cefadroxil for Oral Suspension USP 250 mg/5 ml and 500 mg/5 ml Rx only To reduce the development of drug-resistant bacteria and maintain the effectiveness of cefadroxil for oral suspension and other antibacterial
More informationPage 1 of 32. Community-acquired pneumonia. 10 mg/kg as a single dose on Day 1 followed by 5 mg/kg once daily on Days 2 through 5.
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use AZITHROMYCIN TABLETS safely and effectively. See full prescribing information for AZITHROMYCIN TABLETS.
More informationSee 17 for PATIENT COUNSELING INFORMATION and Medication Guide. Revised: 11/2011
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use LAMICTAL safely and effectively. See full prescribing information for LAMICTAL. LAMICTAL (lamotrigine)
More informationSUCRALFATE TABLETS, USP
1234567890 10 210002 SUCRALFATE TABLETS, USP DESCRIPTION Sucralfate is an -D-glucopyranoside, -D-fructofuranosyl-, octakis-(hydrogen sulfate), aluminum complex. It has the following structural formula:
More informationCore Safety Profile. Pharmaceutical form(s)/strength: Powder for solution for injection, 1 g LV/H/PSUR/0002/001 Date of FAR:
Core Safety Profile Active substance: Ceftriaxone Pharmaceutical form(s)/strength: Powder for solution for injection, 1 g P-RMS: LV/H/PSUR/0002/001 Date of FAR: 14.10.2009 Section 4.2 (Posology and method
More informationEffective pain management begins with OFIRMEV (acetaminophen) injection FIRST Proven efficacy with rapid reduction in pain 1
Effective pain management begins with OFIRMEV (acetaminophen) injection FIRST Proven efficacy with rapid reduction in pain 1 Fast onset of pain relief with 7% reduction in visual analog scale (VAS) scores
More information[Al(OH) 3. ] x [H 2. O]y
CARAFATE (sucralfate) ral Suspension DESCRIPTIN CARAFATE ral Suspension contains sucralfate and sucralfate is an α-d-glucopyranoside, β-dfructofuranosyl-, octakis-(hydrogen sulfate), aluminum complex.
More informationTOUGH ON IMPETIGO GENTLE ON THE1 PATIENT. Demonstrated efficacy and safety1. New treatment option now available!
New treatment option now available! TOUGH ON IMPETIGO GENTLE ON THE1 PATIENT Demonstrated efficacy and safety1 Home Efficacy Safety Convenience (ozenoxacin) is indicated for the topical treatment of impetigo
More informationSee 17 for PATIENT COUNSELING INFORMATION and Medication Guide. Revised: May 2009 LMT:2PI
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use LAMICTAL safely and effectively. See full prescribing information for LAMICTAL. LAMICTAL (lamotrigine)
More informationVORAXAZE (glucarpidase) For Injection, for intravenous use Initial U.S. Approval: 2012
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use VORAXAZE safely and effectively. See full prescribing information for VORAXAZE. VORAXAZE (glucarpidase)
More informationDOSAGE FORMS AND STRENGTHS Tablets: 25 mg, 100 mg, 150 mg, and 200 mg; scored. (3.1, 16)
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use LAMOTRIGINE TABLETS safely and effectively. See full prescribing information for LAMOTRIGINE TABLETS.
More information*Sections or subsections omitted from the full prescribing information are not listed.
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use EGATEN safely and effectively. See full prescribing information for EGATEN. EGATEN (triclabendazole)
More informationFULL PRESCRIBING INFORMATION
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use BACTROBAN Nasal Ointment safely and effectively. See full prescribing information for BACTROBAN Nasal
More informationNEOSPORIN Ophthalmic Solution Sterile (neomycin and polymyxin B sulfates and gramicidin ophthalmic solution, USP)
NEOSPORIN Ophthalmic Solution Sterile (neomycin and polymyxin B sulfates and gramicidin ophthalmic solution, USP) DESCRIPTION Neosporin Ophthalmic Solution (neomycin and polymyxin B sulfates and gramicidin
More informationThe chemical name of acyclovir, USP is 2-amino-1,9-dihydro-9-[(2-hydroxyethoxy)methyl]-6Hpurin-6-one; it has the following structural formula:
Acyclovir Ointment, USP 5% DESCRIPTION Acyclovir, USP, is a synthetic nucleoside analogue active against herpes viruses. Acyclovir ointment, USP 5% is a formulation for topical administration. Each gram
More informationHIGHLIGHTS OF PRESCRIBING INFORMATION
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use epinastine hydrochloride ophthalmic solution safely and effectively. See full prescribing information
More informationSee 17 for PATIENT COUNSELING INFORMATION.
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use NEVANAC* safely and effectively. See full prescribing information for NEVANAC. NEVANAC (nepafenac
More informationReference ID:
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use VERMOX safely and effectively. See full prescribing information for VERMOX. VERMOX (mebendazole)
More informationReference ID:
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ENDARI TM safely and effectively. See full prescribing information for ENDARI. ENDARI (L-glutamine
More informationPRESCRIBING INFORMATION
PRESCRIBING INFORMATION pdp-pyrazinamide Pyrazinamide Tablets, USP 500 mg Antimycobacterial / Antituberculosis Agent PENDOPHARM, Division of Pharmascience Inc.. 6111, Royalmount Ave, Suite 100 Montréal,
More informationXifaxan. Xifaxan (rifaximin) Description
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.01.34 Subject: Xifaxan Page: 1 of 6 Last Review Date: December 8, 2017 Xifaxan Description Xifaxan (rifaximin)
More informationPENICILLIN V POTASSIUM - penicillin v potassium tablet, film coated Aurobindo Pharma Limited
PENICILLIN V POTASSIUM - penicillin v potassium tablet, film coated To reduce the development of drug-resistant bacteria and maintain the effectiveness of penicillin V potassium and other antibacterial
More informationReference ID:
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ZINPLAVA safely and effectively. See full prescribing information for ZINPLAVA. ZINPLAVA (bezlotoxumab)
More informationNOVACEF Tablets (Cefuroxime axetil)
Published on: 6 Oct 2016 NOVACEF Tablets (Cefuroxime axetil) Composition NOVACEF 250 Tablets Each film-coated tablet contains: Cefuroxime Axetil, IP, equivalent to Cefuroxime. 250 mg NOVACEF 500 Tablets
More informationALUNBRIG (brigatinib) Dosing Guide
ALUNBRIG (brigatinib) Dosing Guide INDICATION ALUNBRIG (brigatinib) is indicated for the treatment of patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC)
More informationTo report SUSPECTED ADVERSE REACTIONS, contact Avadel Pharmaceuticals (USA), Inc. at or FDA at FDA-1088 or
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use KARBINAL ER safely and effectively. See full prescribing information for KARBINAL ER. Karbinal ER
More informationWARNING: CLOSTRIDIUM DIFFICILE-ASSOCIATED DIARRHEA (CDAD) and COLITIS See full prescribing information for complete boxed warning.
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use CLINDAMYCIN IN 0.9% SODIUM CHLORIDE injection safely and effectively. See full prescribing information
More informationDays 2 through 5. Community-acquired pneumonia 500 mg as a single dose on Day. 1 followed by 5 mg/kg once daily
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ZITHROMAX safely and effectively. See full prescribing information for ZITHROMAX. ZITHROMAX (azithromycin)
More information13 NONCLINICAL TOXICOLOGY 5.1 Increased Bleeding Time Carcinogenesis, Mutagenesis, Impairment of 5.2 Delayed Healing
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ILEVRO* (nepafenac ophthalmic suspension), 0.3% safely and effectively. See full prescribing information
More informationFULL PRESCRIBING INFORMATION. 1 INDICATIONS AND USAGE 1.1 Treatment of Influenza
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use RELENZA safely and effectively. See full prescribing information for RELENZA. RELENZA (zanamivir)
More informationLAMICTAL XR (lamotrigine) extended-release tablets, for oral use Initial U.S. Approval: 1994
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use LAMICTAL XR safely and effectively. See full prescribing information for LAMICTAL XR. LAMICTAL XR
More informationAerobic gram-positive microorganisms Staphylococcus aureus, Streptococcus agalactiae, Streptococcus pneumonia, Streptococcus pyogenes
AZIMEX Composition Each 5 ml contains Azithromycin (as dihydrate) 200 mg Powder Action Azithromycin acts by binding to the 50S ribosomal subunit of susceptible microorganisms and, thus, interfering with
More informationWARNINGS AND PRECAUTIONS None.
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use PULMOZYME safely and effectively. See full prescribing information for PULMOZYME. PULMOZYME (dornase
More informationKHAPZORY (levoleucovorin) for injection, for intravenous use Initial U.S. Approval: 1952 (d,l-leucovorin)
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use KHAPZORY safely and effectively. See full prescribing information for KHAPZORY. KHAPZORY (levoleucovorin)
More information8 USE IN SPECIFIC POPULATIONS Patients with Open-Angle Glaucoma or Ocular Hypertension
3 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use Isopto Carpine safely and effectively. See full prescribing information for Isopto Carpine. Isopto
More informationMesporin TM. Ceftriaxone sodium. Rapid onset, sustained action, for a broad spectrum of infections
Ceftriaxone sodium Rapid onset, sustained action, for a broad spectrum of infections 1, 2, 3 Antibiotic with a broad spectrum of activity Broad spectrum of activity against gram-positive* and gram-negative
More informationNEW ZEALAND DATA SHEET 2. QUALITATIVE AND QUANTITATIVE COMPOSITION
NEW ZEALAND DATA SHEET 1. PHENOXYMETHYLPENICILLIN AFT Phenoxymethylpenicillin-AFT (granules for oral solution, 125 mg/5 ml and 250 mg/ 5 ml) 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Phenoxymethylpenicillin-AFT
More informationOTIPRIO an antibiotic medicine given to your child at the time of ear tube surgery
Bring this Conversation Starter with you to your child s next doctor appointment an antibiotic medicine given to your child at the time of ear tube surgery Use this questionnaire to start a conversation
More informationNOVACLOX Capsules (Amoxycillin + Dicloxacillin)
Published on: 10 Jul 2014 NOVACLOX Capsules (Amoxycillin + Dicloxacillin) Composition NOVACLOX Capsule Each capsule contains Amoxycillin Trihydrate IP equivalent to Amoxycillin...250 mg Dicloxacillin sodium
More informationHistory of hypersensitivity to AMPYRA or 4-aminopyridine (4)
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use AMPYRA safely and effectively. See full prescribing information for AMPYRA. AMPYRA (dalfampridine)
More information2 QUALITATIVE AND QUANTITATIVE COMPOSITION
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Phenoxymethylpenicillin Sugar Free 250mg / 5ml Powder for Oral Solution 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each 5ml contains 277.2mg
More informationFIRDAPSE (amifampridine) tablets, for oral use Initial U.S. Approval: 2018
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use FIRDAPSE safely and effectively. See full prescribing information for FIRDAPSE. FIRDAPSE (amifampridine)
More informationM0BCore Safety Profile
M0BCore Safety Profile Active substance: Clindamycin Pharmaceutical form(s)/strength: 300mg/2 ml Ampulle, 600 mg/4 ml Ampulle, 900 mg/6 ml Ampulle, 75 mg/5 ml Granulat für orale Lösung, 150 mg Kapselnn,
More informationSee 17 for PATIENT COUNSELING INFORMATION. Revised 01/2016
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use MEGACE ES safely and effectively. See full prescribing information for MEGACE ES. MEGACE ES (megestrol
More informationSummary of Product Characteristics
1 NAME OF THE MEDICINAL PRODUCT Oramox (Amoxicillin Oral Suspension BP) 125mg / 5ml Summary of Product Characteristics 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each 5ml of reconstituted suspension contains
More informationDALFAMPRIDINE Extended-release tablets, for oral use. Initial U.S. Approval: 2010
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use DALFAMPRIDINE EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for
More information